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a b s t r a c t
An epitope-blocking enzyme-linked immunosorbent assay (bELISA) was developed for the detection of
antibodies to influenza A virus in taxonomically diverse domestic and wild vertebrate species. In contrast
to the bELISAs published previously that require reagent production, manipulation by the end-user, or
have not been evaluated for use with both mammalian and avian species, this assay is performed using
commercially available recombinant nucleoprotein antigen and corresponding nucleoprotein-specific
monoclonal antibody and has been shown to work with multiple avian and mammalian species. The
efficacy of the bELISA as a serum screening assay was compared to the agar gel immunodiffusion (AGID)
assay using 251 serum samples obtained from experimentally infected mallards (Anas platyrhynchos) and
raccoons (Procyon lotor). The concordance between the AGID assay and bELISA was 94.1% (95% CI =89.9,
98.3) for raccoons, and 71.2% (95% CI =63.5, 78.9) for mallards and 82.8% (95% CI =78.2, 87.3) overall.
The bELISA was more sensitive than the AGID assay as demonstrated by the detection of antibodies to
influenza A virus at earlier time points in experimental infection studies and at higher serial dilutions.
The efficacy of the bELISA to monitor natural influenza A virus exposure was also compared to the AGID
assay using an additional 745 serum samples from six avian species and six mammalian species. This
bELISA provides a rapid, reliable, and inexpensive technique for large-scale surveillance of influenza A
virus exposure in taxonomically diverse vertebrate species.
Published by Elsevier B.V.
1. Introduction
Influenza viruses (family Orthomyxoviridae) are segmented,
negative-sense, single-stranded RNA viruses that are classified into
three types (A, B and C) based on the antigenic properties of their
nucleoproteins (NP) and matrix proteins (Webster et al., 1992).
Influenza A viruses are further classified into different subtypes
based on the antigenicity of their hemagglutinin (HA) and neu-
raminidase (NA) proteins (Spackman, 2008). To date, sixteen HA
subtypes (H1–H16) and nine NA subtypes (N1–N9) of influenza A
virus have been identified (Fouchier et al., 2005). While all known
subtypes of influenza A virus are maintained in waterfowl (Fenner
et al., 1993), these viruses have a broad host range that includes
numerous avian and mammalian species (Palese and Shaw, 2007).
Recently, the Asian strain of highly pathogenic avian influenza
∗ Corresponding author. Tel.: +1 970 266 6123; fax: +1 970 266 6138.
E-mail address: Heather.Sullivan@aphis.usda.gov (H.J. Sullivan).
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(HPAI) H5N1 has attracted world-wide attention because it has
been responsible for significant mortality in many domestic and
wildlife species and has caused over 380 human cases of influenza
A (H5N1) in Asia, Europe and Africa (WHO, 2008). Due to the rapid
spread of HPAI H5N1, surveillance studies have been initiated to
monitor the activity and spreadofmultiple influenzaAviruses (Hall
et al., 2008a,b; Paltrinieri et al., 2008; U.S. Interagency Strategic
Plan, 2006).
One way to monitor influenza A virus activity in an area is to test
serum samples from domestic and/or wild animals for the pres-
ence of antibodies. Traditionally, the serological tests suggested for
large numbers of serum samples from domestic and/or wild animal
studies have included the agar gel immunodiffusion (AGID) assay
which detects the presence of antibodies to all influenza A viruses
and the hemagglutination-inhibition (HI) test which detects anti-
bodies to specific HA subtypes of influenza A viruses (OIE, 2008).
The HI test is not typically utilized for large-scale influenza A virus
serological surveysbecausemany researchers donothave the facili-
ties, reagents, or funds to conduct numerous HI assays for all 16 HA
subtypes. Due to its ability to detect antibodies to all influenza A
0166-0934/$ – see front matter. Published by Elsevier B.V.
doi:10.1016/j.jviromet.2009.06.001
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viruses the AGID assay can be useful when screening large num-
bers of animals for the evidence of any influenza A virus exposure.
However, while the AGID assay has been shown to work well with
some species, such as poultry, it has not been thoroughly validated
for use with others (Beard, 1970; OIE, 2008). Some species, such
as mallards and swine, may not produce precipitating antibodies
consistently, which are necessary for the AGID assay to perform
properly (Beard, 1970;Higgins, 1989; Toth andNorcross, 1981). Due
to possible constraints of the AGID assay various enzyme-linked
immunosorbent assays (ELISAs) have been developed to detect
antibodies to influenza A viruses from multiple species (Shafer et
al., 1998; Starick et al., 2006;Wuet al., 2007).However, these ELISAs
require extensive reagent production andmanipulation,whichmay
not be feasible formany researchers. The objective of this studywas
to develop an epitope-blocking ELISA (bELISA), using commercially
available reagents thatwould provide research anddiagnostic labo-
ratories a rapid and inexpensive method to screen large numbers of
serum samples fromboth domestic andwild animals for antibodies
to all influenza A viruses. The utility of the bELISA was examined
relative to the AGID assay by testing serum from known infected
and control animals.
2. Materials and methods
2.1. Reagent evaluation
Direct ELISAs were performed to ensure that the commercial
monoclonal antibody and nucleoprotein antigen could suffi-
ciently bind and produce an enzymatic reaction measurable by
a spectrophotometer. For the bELISA, these reagents were then
independently optimized using well-characterized serum samples
from experimentally infected and mock infected mallards (Anas
platyrhynchos). All serum samples were tested in duplicate at a
dilution of 1:10. The antigen was optimized using a range of con-
centrations from1.6g/ml to 100mg/ml. Themonoclonal antibody
was optimized using a range of concentrations from 1.6g/ml to
50mg/ml. Concentrations that resulted in the greatest percent inhi-
bition of monoclonal antibody binding were then used throughout
the analyses.
2.2. Serum samples
A total of 251 serum samples from experimentally infected ver-
tebrates and 745 serum samples collected in serological surveys
belonging to 12 species (eight orders, 12 families) were used to
evaluate the bELISA. Serum samples were obtained from raccoons
(Procyon lotor), and mallards which were challenged experimen-
tally with four different subtypes of influenza A virus. Eight
raccoons were inoculated intranasally with 105 EID50 of influenza
A virus subtypeH4N8 (A/CK/AL/75[H4N8]), and four raccoonswere
inoculated intranasally with 105 EID50 of influenza A virus sub-
typeH3N2 (A/Aichi/2/68 [H3N2]) (10). Twenty-threemallardswere
orally inoculated with 106 EID50 of influenza A virus subtype H4N6
(A/wildbird/PA/185996-06/07[H4N6]) and 27 mallards were orally
inoculated with 104 EID50 of influenza A virus subtype H8N4 (A/
wildbird/CA/186243-18/06[H8N4]).
Additionally, sera were obtained from 215 birds and 38 mam-
mals from Maryland in 2005 and 2006 and used to determine the
diagnostic criterion for the bELISA. Avian species sampled from
Marylandwere as follows: Canada geese (Branta canadensis; n=98),
great blue herons (Ardea herodias; n=8), a dark-eyed junco (Junco
hyemalis; n=1), mallards (n=22), American white pelicans (Peli-
canus erythrorhynchos;n=20), rockdoves (Columba livia;n=18) and
wood ducks (Aix sponsa; n=48) and mammalian species included
American black bears (Ursus americanus; n=10), woodchucks (Mar-
mota monax; n=9), raccoons (n=10), red fox (Vulpes vulpes; n=1),
and white-tailed deer (Odocoileus virginianus; n=8). Sera were also
obtained from 323 Canada geese sampled in Pennsylvania in 2003,
122 feral swine (Sus scrofa) sampled in Texas in 2005–2006 (Hall
et al., 2008a), 16 raccoons sampled in a suburban area in Colorado
in 2006 (Root et al., 2008), and 31 rock doves (C. livia) sampled in
Idaho in 2008 and used to evaluate the efficacy of the bELISA in
naturally exposed wildlife.
2.3. Epitope-blocking enzyme-linked immunosorbent assay
The bELISA platform used was similar to a published bELISA
used for West Nile virus surveillance (Blitvich et al., 2003a,b).
Briefly, the inner 60 wells of 96-well microtiter plates (Corning Inc.,
Corning, NY) were coated with 100l of recombinant influenza
A virus nucleoprotein (Cat no. IMR-274; Imgenex, San Diego, CA)
diluted optimally at approximately 143mg/ml (prior to multi-
ple freeze–thaw cycles) in carbonate–bicarbonate buffer (50mM
sodium carbonate, 50mM sodium bicarbonate, pH 9.6). The outer
wells were filled with carbonate–bicarbonate buffer only. Coated
plateswere incubated overnight at 4 ◦C andwashed four timeswith
wash buffer (phosphate-buffered saline [PBS, pH 7.5] containing
0.1% Tween 20). Next, 200l of blocking buffer (PBS containing 5%
skim milk) was added to each well and incubated for 40min at
37 ◦C. After an additional four washes, 50l of serum diluted 1:10
in blocking buffer was added in duplicate and incubated for 2h at
37 ◦C, after which the wells were washed again four times. Next,
50l of the influenza A virus nucleoprotein-specific monoclonal
antibody clone A1 (Cat. No. MAB8257; Millipore Corp., Billerica,
MA) optimally concentrated at 50mg/ml in blocking buffer was
added to each well and incubated for 1h at 37 ◦C. Plates were again
washed four times and 50l of horseradish peroxidase-conjugated
rabbit anti-mouse IgG (Invitrogen, Carlsbad, CA) was added at a
concentration of 500mg/ml to each well and incubated for 1h
at 37 ◦C, followed by four washes. Equal volumes of ABTS (2,2′
azino-bis[3-ethylbenzthiazoline-6-sulfonic acid]) and peroxidase
solutions from the ABTS Microwell peroxidase substrate system
(KPL, Gaithersburg, MD) were mixed, and 75l was added to each
well. The optical density at awavelength of 415nmwas determined
with a spectrophotometer once negative controls reached an opti-
cal density of 0.30. The percent inhibition of monoclonal antibody
binding was calculated as 100− [(TS−B)/(CS−B)]×100, where TS
is the mean optical density of the test serum, CS is the mean optical
density of the control serum (negative control serum from unin-
fected raccoonsormallards, dependingon the speciesbeing tested),
and B is the background optical density. For estimation of the back-
ground optical density, four wells of each plate were incubated
with coating buffer that did not contain influenza A virus nucle-
oprotein antigen. Serum samples were tested in duplicate, and at
least four wells of negative control serum were included on each
96-well plate. The reagent and sample volumes and optical den-
sity of 0.3 (the negative control serum cut off) used are based on
well-established and routinely used bELISA protocols (Blitvich et
al., 2003a,b; Hall et al., 1995).
2.4. Traditional influenza A virus serological assays
The AGID assay was performed according to a standard proto-
col (Woolcock, 2008). The antigen used in the assay was derived
from the conserved influenzaAvirus nucleoprotein andmatrix pro-
tein. Reagents were provided by the National Veterinary Service
Laboratories (NVSL) in Ames, IA. The hemagglutination-inhibition
(HI) and neuraminidase-inhibition (NI) tests were performed at
the NVSL following standard protocols (Killian, 2008; Pedersen,
2008).
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Table 1
Percent concordance between the AGID assay and the bELISA for antibody detection in serum collected from influenza A virus experimental infection studies.
Species-subtype No. of serum samples % positive AGID (95% CI) % positive bELISA (95% CI) % concordance (95% CI)
Raccoon-H3N2 41 29.3 (15.3, 43.2) 41.5 (26.4, 56.5) 87.8 (77.8, 97.8)
Raccoon-H4N8 78 24.4 (14.8, 33.9) 26.9 (17.1, 36.8) 97.4 (93.9, 100.9)
Mallards-H4N6 48 33.3 (20.0, 46.7) 45.8 (31.7, 59.9) 81.3 (70.2, 92.3)
Mallards-H8N4 84 48.8 (38.1, 59.5) 83.3 (75.4, 91.3) 65.5 (55.3, 75.6)
Total 251 82.1 (77.3, 87.6)
2.5. Comparison of detection levels between bELISA and the AGID
assay
To assess further the sensitivity of the bELISA, 18 arbitrarily
selected serum sampleswere used in a dilution experiment. Briefly,
sera from animals challenged experimentally (mallard and rac-
coon) and three naturally exposed raccoonswere tested atmultiple
dilutions by bELISA and AGID assay. Serum samples were diluted
serially two-fold, with a starting dilution of 1:10 and a final dilu-
tion of 1:1280. Each serum sample was also tested undiluted. The
last dilution in which the binding of the monoclonal antibody
was inhibited significantly was considered the detection thresh-
old for the bELISA and the last dilution in which a precipitation line
was observed was considered the detection threshold for the AGID
assay.
2.6. Statistical analysis
The efficacy of the bELISA was compared to the AGID assay
using sera from experimentally and mock challenged raccoons
and mallards. Each sample analyzed by both the bELISA and AGID
assay was scored as to whether they agreed or disagreed that
antibodies had been detected. Using these data, percent concor-
dance with 95% confidence intervals were calculated to estimate
the agreement between the two assays. A kappa statistic () was
used to measure the strength of this agreement as a chance-
corrected proportional agreement ranging from 0 (indicating no
agreement above that expected by chance) to 1 (indicating per-
fect agreement) (Landis and Koch, 1977). Next a logistic regression
(Hosmer and Lemeshow, 2000) was used to compare detection
rates of antibodies to influenza A virus in sera from experimen-
tally challenged raccoons and mallards (both negative control and
infected animals) using the bELISA and AGID assay. The response
variable in this model was binary, with one indicating antibodies
to influenza A virus were detected and zero indicating they were
not detected. Explanatory variables used in the analysis included
method (bELISA or AGID assay), species (mallard or raccoon) and
days post-inoculation. PROC LOGISTIC in SAS® was used to ana-
lyze the data in models representing different combinations of the
explanatoryvariableswith andwithout interactions (Allison, 1999).
The logistic regression model best explaining the data was selected
using information-theoretic model selection based on corrected
Akaike Information Criterion (AICc) and Akaike weights (Burnham
and Anderson, 2003). In the selected model, odds ratios for the
method was computed to determine whether one method per-
formed better than the other and maximum-rescaled R2 was used
to estimate how much variation in the data was explained by the
logistic regression model (Hosmer and Lemeshow, 2000).
3. Results
3.1. Determining the diagnostic criterion
To determine the positive threshold for the bELISA 245 serum
samples were used from Maryland from six wild bird (Canada
goose, great blue heron, dark-eyed Junco, American white pelican,
rock dove, mallard, and wood duck) and five wild mammal species
(American black bear, groundhog, raccoon, red fox andwhite-tailed
deer) negative for antibodies to influenza A virus by the AGID assay.
However, twenty-four of these serum samples (Canada goose, mal-
lard and wood duck) inhibited the binding of the monoclonal anti-
body by ≥30% using the bELISA. Eight of these samples were sub-
mitted to the NVSL for HI and NI testing, the remaining 16 samples
had insufficient volumes. Of these, seven (87.5%) yielded evidence
of antibodies to influenza A virus by the HI and/or NI test. These
samples and the remaining serum samples that had inhibited the
binding of the antibodies to influenza A virus monoclonal antibody
in the bELISA were therefore removed from the analysis for deter-
mining the positive threshold. Themean inhibition value of the 222
remaining negative serum sampleswas 4.3%with a standard devia-
tion of 13.5%. Therefore, an inhibition value of 32% (mean inhibition
value±2S.D.)was selectedas thediagnostic criterion to indicate the
presence of antibodies to influenza A virus by the bELISA.
3.2. Evaluation of the bELISA using serum samples from
experimentally challenged animals
The diagnostic efficacy of the bELISA was evaluated using serum
samples obtained from experimentally challenged raccoons and
mallards (Table 1). In the experiments performed with raccoons,
all four raccoons challenged with a H3N2 subtype seroconverted
and three of the eight raccoons challenged with a H4N8 subtype
seroconverted, which was demonstrated in the bELISA as well as
the AGID assay. In all instances, the bELISA detected the antibodies
to influenza A virus either prior to or concurrently with the AGID
assay post-inoculation. Antibodies to influenza A virus were not
detected in any of the negative control raccoons by either bELISA
or the AGID assay. The concordance between the AGID assay and
bELISA in these experimental raccoon infection studies was 94.1%
(95% CI =89.9, 98.3; Table 1) with  =0.858 (95% CI =0.757, 0.959),
indicating strong agreement between AGID assay and bELISA for
this species.
Sevenof 48 (14.6%) serumsamples collected frommallards inoc-
ulated with influenza A virus subtype H4N6 tested positive by
bELISA andnegative by theAGIDassay.One serumsamplewasposi-
tive by theAGID assay but negative by bELISA. For the second cohort
of mallards inoculated with influenza A virus subtype H8N4, 29 of
the 84 (34.5%) serum samples tested positive for the antibodies to
influenza A virus by the bELISA and negative by the AGID assay. The
concordance between the AGID assay and bELISA in these exper-
imental mallard infection studies was 71.2% (95% CI =63.5, 78.9;
Table 1),with  =0.468 (95%CI =0.342, 0.594), indicating onlymod-
erate agreement between AGID assay and bELISA for this species.
This agreement for mallards was significantly lower than for the
inoculated raccoons.
For the 251 mallard and raccoon serum samples evaluated from
these experimental inoculations, the overall concordance between
the AGID assay and bELISA was 82.1% (95% CI =77.3, 86.8; Table 1)
with  =0.653 (95% CI =0.565, 741), which indicated moderate
agreement between AGID assay and bELISA.
In the logistic regression analysis, a model incorporating the
variables: species (mallards versus raccoons), method (AGID assay
versus bELISA), days post-inoculation and the interaction between
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species and method was selected based on minimum AICc over
other models having fewer effects. The selected model had an
Akaike weight of 0.91, indicating it explained the data substantially
better than othermodels in the set ofmodels examined. Thismodel
also explained 36.3% of the variation in the data. Based on odds
ratios, this model indicated that overall the bELISA was 2.5 (95%
CI =1.6, 3.8) times more likely than the AGID assay to detect anti-
bodies to influenza A virus in experimentally challenged animals.
However, the odds ratio for mallards indicated that the bELISA was
5.8 (95% CI =2.9, 11.7) times more likely than the AGID assay to
detect antibodies, whereas the odds ratio for raccoons indicated
that the bELISA was only 1.3 (95% CI =0.76, 2.4) times more likely
than the AGID assay to detect antibodies. In addition, the odds ratio
for raccoons was not statistically different than 1 (i.e., no differ-
ence), based on the 95% confidence intervals. Thus,when compared
to the AGID assay, the bELISA was more efficacious when used to
assay serum samples from mallards as compared to raccoons and
this effect of detectability between the two methods appeared to
be greater in mallards at earlier time points in the infection period
whereas the effect in raccoons was more constant across the infec-
tion period (Fig. 1).
Fig. 1. Probability of detecting antibodies to influenza A virus using the bELISA
and AGID assay on days post-inoculation for experimentally challenged (A) mal-
lards and (B) raccoons based on a logistic regression model that included effects of
species (mallard versus raccoon), method (bELISA versus AGID assay) and days post-
inoculation. The dotted lines represent probability of detecting antibodies based on
bELISA and solid lines represent probability of detecting antibodies based on AGID
assay.
Table 2
Determination of the antibodies to influenza A virus detection levels in selected
mallard and raccoon serum samples by bELISA and the AGID assay.
Sample ID Blocking ELISA dilution AGID dilution
aM1 1:640 1:10
M2 1:640 1:1
M3 1:640 1:1
M4 ≥1:1280 1:1
M5 ≥1:1280 1:1
M6 1:640 1:1
M7 1:640 1:1
M8 1:160 1:1
M9 ≥1:1280 1:1
bR1 ≥1:1280 1:1
R1 1:640 1:1
R2 ≥1:1280 1:10
R3 ≥1:1280 1:160
R4 1:320 1:10
cNR1 ≥1:1280 1:10
NR2 1:40 1:1
NR3 ≥1:1280 1:1
a M: influenza A virus experimentally challenged mallard.
b R: influenza A virus experimentally challenged raccoon.
c NR: influenza A virus naturally exposed raccoon.
3.3. Utility of the bELISA in determining natural exposure to
influenza A virus in wild populations
Serum samples (n=492) were tested for antibodies to influenza
A virus using the AGID assay and bELISA. The concordance between
the two tests was 93.5, 87.7, 87.5 and 63.5% in rock doves (n=31),
feral swine (n=122), raccoons (n=16) and Canada geese (n=323),
respectively. To investigate discrepancies between the bELISA and
AGID assay results, a subset of serum samples from each species
was sent to the NVSL in Ames, IA for standard HI and NI confirma-
tion/subtyping testing. For samples that were positive by bELISA
but negative by the AGID assay, the HI and/or NI tests agreed with
the bELISA 26/28 (92.3%) times. In samples that tested negative by
bELISA but positive by AGID assay, the HI and/or NI tests agreed
with the bELISA 2/9 (22.2%) times. Canada geese were exposed to
HA subtypes (H1, H4, H5 and H6) and NA subtypes (N1, N2, N4, N6
and N8). Rock doves were exposed to HA subtypes (H1 and H4) and
NA subtypes (N7 and N8). Feral swine were exposed to the NA sub-
typeN2. NoHA subtypeswere identified from these swine samples.
Raccoons were exposed to HA subtype H3.
3.3.1. Comparison of detection levels between bELISA and the
AGID assay
The last dilution in which the binding of the monoclonal anti-
body was significantly inhibited for the bELISA was ≥1:1280, and
the last dilution that presented a precipitation line for the AGID
assay was 1:160 (Table 2).
4. Discussion
There are several diagnostic assays available for influenzaAvirus
serological studies (OIE, 2008). However, each diagnostic assay has
limitations. TheHI is used to confirmandsubtype samples thathave
tested positive for influenza A virus antibodies using an assay used
for screening. The HI test is expensive, subtype-specific, requires a
large volume of serum which is problematic when working with
small passerines or mammals such as rodents. The HI on occasion
requires modification when testing mammals and some wild bird
species for exposure to avian derived influenza A virus (Lu et al.,
1982; Kida et al., 1994; Ninomiya et al., 2002; Cattoli and Capua,
2007; VanDalen et al., 2009). Therefore, it is cost prohibitive and
is not typically used for large-scale serological surveys for screen-
ing samples for influenza A virus in mammals and some wild bird
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species. The AGID assay has been the traditional screening assay or
‘gold standard’whendealingwith a large number of serumsamples
for antibodies to influenza A virus during surveillance studies in
poultry. While this test is able to detect antibodies to all influenza A
virus subtypes, it is very subjective and prone to misinterpretation,
requires ten times the volume of sera compared to the bELISA, and
may not be ideal for use with all species (Higgins, 1989). The previ-
ously described bELISAs for the detection of antibodies to influenza
A virus require the purification of the monoclonal antibodies to
influenza A virus from hybridoma cells and expression and purifi-
cation of the recombinant nucleoprotein antigen from insect cells
infectedwith recombinant baculoviruses (de Boer et al., 1990; Zhou
et al., 1998; Shafer et al., 1998; Starick et al., 2006). These additional
steps are cost and time prohibitive and may not be feasible in many
laboratories. Theefficacyofmost ELISAsused todetect antibodies to
influenzaAvirus inwildlife havenot yet been thoroughly evaluated.
Recently, a commercial ELISA kit (Multi-S kit, IDEXX, Westbrook,
ME) has been made available for screening mallard, goose, turkey,
chicken and ostrich serum for antibodies to influenza A virus, but
the kit is costly and has not been thoroughly evaluated for testing
mammal serum.
Due to the constraints mentioned above, our laboratory sought
to develop a bELISA using commercially available reagents that
would be rapid, cost effective, and could be used for multiple
species. Conventionally, when attempting to validate a new assay,
it is a common practice to statistically compare results from the
new assay to a ‘gold standard’ assay (defined as assessing infection
status with certainty) to estimate the accuracy (i.e., sensitivity and
specificity) of the new assay. Since the AGID assay used to screen
influenza A virus antibodies in poultry has not yet been thoroughly
evaluated for wildlife and has known limitations, the bELISA was
compared to the AGID assay, but without a ‘gold standard’. There-
fore, sensitivity and specificity were not calculated. Instead percent
concordance was calculated, which was 71.2% (95% CI =63.5, 78.9;
Table 1) for avian species and 94.1% (95% CI =89.9, 98.3; Table 1)
for the mammalian species evaluated. Based on logistic regression
the variation found in the data from experimental infections was
best explained in amodel incorporating species,method, days post-
inoculation, and interaction between species and method. In an
attempt to evaluate thediscrepancies between thebELISA andAGID
assay, a subset of samples (n=37)was sent to theNVSL, Ames, IA for
HI testing. While it would have been advantageous to confirm and
subtype all of the samples using the HI assay, this was not possible
because of budget constraints (estimated cost $37,000). From our
subset of samples, the HI test and/or NI test agreed with the bELISA
in 67% (24/36) of the samples and agreed with the AGID assay in
only 33% (12/36) of the samples. These data provide additional evi-
dence that the bELISA is more reliable than the AGID assay for the
detection of influenza A antibodies. In addition, some studies have
shown the standard HI protocol (Killian, 2008) can produce false-
negative results for certain mammal and avian samples (Lu et al.,
1982; Kida et al., 1994; Ninomiya et al., 2002; Cattoli and Capua,
2007; VanDalen et al., 2009). Therefore, estimates of agreement
above may be underestimated.
There are several distinct advantages in using this bELISA for
large-scale, multi-species serological surveys. This bELISA is not
subtype-specific, it is more objective than some traditional tech-
niques (i.e., AGID assay), it requires small volumes of sera and can
be performed using commercially available reagents. Because the
reagents can be used at very high optimal dilutions (143mg/ml for
the nucleoprotein antigen and 50mg/ml for the monoclonal anti-
body) and test samples at lowvolumes, the bELISA is an inexpensive
and specimen conservative screening assay. In addition, when the
detection levels were compared between the bELISA and the AGID
assay it was shown that the likelihood of detecting serum samples
with low titers of antibodies to influenza A virus is improved when
using thebELISAas compared to theAGIDassay (Table 2). Itwas also
shown that the bELISA will detect antibodies to influenza A virus
earlier to post-infection in experimentally challenged raccoons and
mallards,when compared to theAGID assay (Fig. 1). The bELISAwas
able to detect antibodies to influenza A virus in a number of differ-
ent avian and mammalian species exposed to multiple influenza A
virus subtypes.
5. Conclusion
In summary, a sensitive, inexpensive, objective, species-
independent bELISA platform has been developed, that can be
performed in most laboratories and can screen for a variety of
influenza A virus-specific subtypes. For these reasons this assay is
ideal for large-scale serological studies in multiple domestic and
wild mammalian and avian species.
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